UNILEVERCL Stock Overview
Manufactures and markets consumer healthcare products in Bangladesh.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Unilever Consumer Care Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ৳2,147.20 |
| 52 Week High | ৳2,310.00 |
| 52 Week Low | ৳1,801.00 |
| Beta | 0.033 |
| 1 Month Change | 7.26% |
| 3 Month Change | 1.35% |
| 1 Year Change | 5.62% |
| 3 Year Change | 22.59% |
| 5 Year Change | 149.19% |
| Change since IPO | 2,715.08% |
Recent News & Updates
Recent updates
Shareholder Returns
| UNILEVERCL | BD Food | BD Market | |
|---|---|---|---|
| 7D | 16.1% | 2.2% | -2.6% |
| 1Y | 5.6% | -6.7% | -19.8% |
Return vs Industry: UNILEVERCL exceeded the BD Food industry which returned -6.7% over the past year.
Return vs Market: UNILEVERCL exceeded the BD Market which returned -19.8% over the past year.
Price Volatility
| UNILEVERCL volatility | |
|---|---|
| UNILEVERCL Average Weekly Movement | 4.6% |
| Food Industry Average Movement | 6.0% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in BD Market | 7.8% |
| 10% least volatile stocks in BD Market | 3.1% |
Stable Share Price: UNILEVERCL has not had significant price volatility in the past 3 months.
Volatility Over Time: UNILEVERCL's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1974 | 71 | Khan Salahuddin Minhaj | www.unilever.com/ucl-bd |
Unilever Consumer Care Limited manufactures and markets consumer healthcare products in Bangladesh. It offers health food drinks and glucose powder under the brand name Horlicks, Boost, Maltova, and GlucoMaxD. The company was formerly known as GlaxoSmithKline Bangladesh Limited.
Unilever Consumer Care Limited Fundamentals Summary
| UNILEVERCL fundamental statistics | |
|---|---|
| Market cap | ৳41.39b |
| Earnings (TTM) | ৳984.03m |
| Revenue (TTM) | ৳3.81b |
42.1x
P/E Ratio10.9x
P/S RatioIs UNILEVERCL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| UNILEVERCL income statement (TTM) | |
|---|---|
| Revenue | ৳3.81b |
| Cost of Revenue | ৳2.19b |
| Gross Profit | ৳1.62b |
| Other Expenses | ৳633.96m |
| Earnings | ৳984.03m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 51.05 |
| Gross Margin | 42.48% |
| Net Profit Margin | 25.84% |
| Debt/Equity Ratio | 23.4% |
How did UNILEVERCL perform over the long term?
See historical performance and comparison